Showing results (691-700 of 780) with videos related to
Sort By:
Pageof 78
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcomaPeter W T Pisters, Matthew T Ballo, Mark J Fenstermacher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2010
Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trialRashmi Chugh, J Kyle Wathen, Shreyaskumar R Patel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Prognostic factors for survival of patients treated systemically for disseminated melanomaO Eton, S S Legha, T E Moon, et al.Oncogene|May 9, 2007
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signalingK Shtiegman, B S Kochupurakkal, Y Zwang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomasF Meric, M Milas, K K Hunt, et al.Animals : an Open Access Journal From MDPI|February 15, 2022
Modelling the Relative Abundance of Roe Deer (Capreolus capreolus L.) along a Climate and Land-Use GradientCaryl S Benjamin, Lars Uphus, Marvin Lüpke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging systemA C Buzaid, M I Ross, C M Balch, et al.Cancer|December 21, 2006
Chemotherapy response is an important predictor of local recurrence in Ewing sarcomaPatrick P Lin, Norman Jaffe, Cynthia E Herzog, et al.Blood|September 15, 1995
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I studyS Vadhan-Raj, H E Broxmeyer, M Andreeff, et al.The Oncologist|December 8, 2017
Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell TumorBrian A Menegaz, Branko Cuglievan, Jalen Benson, et al.Pageof 78